Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor with respect to certain entities participating in a federal drug discount program.
Impact
If enacted, HB4422 will significantly affect the Insurance Code by adding a new subchapter dedicated to prohibiting discrimination based on 340B participation. The implications of this bill may extend to various health system stakeholders, as it will prohibit actions that could hinder the ability of covered entities to provide access to affordable medications. This legislative move seeks to uphold fairness in drug reimbursement mechanisms, ultimately aiming to benefit vulnerable populations served by these entities.
Summary
House Bill 4422 addresses discriminatory practices by health benefit plan issuers, pharmacy benefit managers, and third-party payors in relation to entities participating in the federal 340B drug discount program. Specifically, the bill aims to create a legal framework to ensure that covered entities in the 340B program are not subjected to unfair treatment compared to non-covered entities. This includes provisions to prevent discriminatory pricing practices that might disadvantage these entities in the procurement of prescription drugs.
Contention
Key points of contention surrounding HB4422 may arise from varying perspectives among health benefit plan issuers and pharmacy benefit managers. While proponents argue that the bill protects entities in the 340B program and enhances patient access to necessary medications, opponents may voice concerns about the operational and financial burdens that could result from increased regulatory oversight. The discourse may focus on how this balance of interests is handled and whether it appropriately addresses the potential impact on overall healthcare costs.
Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.
Prohibits any health insurer, pharmacy benefit manager, manufacturer or other third-party payor from discriminating against any 340B entity participating in a drug discount program.
Prohibits any health insurer, pharmacy benefit manager, manufacturer or other third-party payor from discriminating against any 340B entity participating in a drug discount program.
Relating to funding of excess losses and operating expenses of the Texas Windstorm Insurance Association; authorizing an assessment; authorizing a surcharge.
Relating to compensation and employment condition standards by municipal charter or collective bargaining agreement and to impasse resolution in collective bargaining with certain political subdivisions.